| Syndrome | Target | First-Line Drug |
|---|---|---|
| Hypertensive encephalopathy | MAP reduction 20–25% in 1h | Nicardipine or labetalol IV |
| Aortic dissection (Type A/B) | SBP < 120, HR < 60 ASAP | Esmolol + nitroprusside or nicardipine |
| Acute pulmonary edema | Rapid reduction | Nicardipine + nitroglycerin IV + diuresis |
| ACS with hypertension | SBP < 140 | Nitroglycerin IV + beta-blocker |
| Ischemic stroke | Only treat if BP > 220/120 (no tPA) or > 185/110 (if tPA candidate) AHA/ASA, 2019 | Labetalol or nicardipine IV -go slow |
| Hemorrhagic stroke | SBP < 140 ATACH-2, 2016 INTERACT2, 2013 | Nicardipine or labetalol IV |
| Eclampsia | SBP < 160, DBP < 110 | Labetalol IV or hydralazine IV + MgSO₄ MAGPIE, 2002 |
| Pheochromocytoma crisis | MAP reduction 20–25% | Phentolamine IV -α-blockade first, then add beta-blocker |
| Drug | Dose | Onset | Best For | Avoid In |
|---|---|---|---|---|
| Nicardipine (Cardene) | 5–15 mg/hr IV drip | 5–10 min | Most hypertensive emergencies. Excellent titratable agent. | Advanced aortic stenosis |
| Labetalol (Trandate) | 20–80 mg IV bolus q10min, or 0.5–2 mg/min drip | 5 min | Aortic dissection, stroke, eclampsia | Asthma, severe bradycardia, acute HF |
| Esmolol (Brevibloc) | 500 mcg/kg bolus, then 50–200 mcg/kg/min | 1–2 min | Aortic dissection (HR control) | Bronchospasm, bradycardia |
| Sodium Nitroprusside | 0.3–10 mcg/kg/min | Seconds | Hypertensive emergency when other agents fail | Renal failure (cyanide toxicity), elevated ICP, pregnancy |
| Nitroglycerin (Nitrostat) | 5–200 mcg/min IV | 1–2 min | Pulmonary edema, ACS | Aortic dissection (reflex tachycardia), PDE5 inhibitor use |
| Hydralazine (Apresoline) | 10–20 mg IV q4–6h | 10–20 min | Eclampsia (if labetalol not available) | Aortic dissection, aortic aneurysm (reflex tachycardia worsens shear stress), CAD (unpredictable response, reflex tachycardia), elevated ICP |
| Test | Looking For | End-Organ Damage |
|---|---|---|
| BMP + Cr | Cr above baseline | Renal: AKI from malignant nephrosclerosis |
| UA + microscopy | Proteinuria, hematuria, RBC casts | Renal: Active sediment = hypertensive nephropathy |
| Troponin | Elevated, rise-fall | Cardiac: Demand ischemia or ACS from afterload |
| ECG | LVH, ST/T changes, new arrhythmia | Cardiac: Acute ischemia, atrial strain |
| CXR | Pulmonary edema, wide mediastinum | Cardiac: Flash pulmonary edema. Wide mediastinum → CTA for dissection |
| Fundoscopy | Flame hemorrhages, papilledema | Retinal/CNS: Grade III-IV = malignant HTN |
| CT head | Hemorrhage, PRES, ischemia | CNS: Order if headache, AMS, focal deficits, seizures, visual changes |
| Peripheral smear | Schistocytes, low platelets | Hematologic: MAHA from shear stress. Check LDH ↑, haptoglobin ↓ |
| BNP | Elevated | Cardiac: Flash pulmonary edema from afterload crisis |
| Urine drug screen | Cocaine, amphetamines | Etiology: Avoid beta-blockers with cocaine (unopposed alpha) |
| Pregnancy test | Positive β-hCG | Etiology: Pre-eclampsia/eclampsia → magnesium + delivery |
Patient: 54M, non-adherent to amlodipine and lisinopril, presents with headache, blurred vision, and nausea. No chest pain or focal neurologic deficits.
Key findings: BP 238/142, HR 92. Fundoscopy: flame hemorrhages + papilledema. Cr 3.4 (baseline 1.2), proteinuria 3+, hematuria. CT head negative. TTE: LVH, EF 55%.
Management:
Teaching point: Hypertensive nephrosclerosis with acute end-organ damage (AKI + papilledema) defines hypertensive emergency. Nicardipine is first-line for most hypertensive emergencies: smooth, titratable, no CNS depression. Renal function often improves with controlled BP reduction.
Patient: 72F, HTN and AF (not on anticoagulation), presents with acute right-sided weakness and aphasia. Symptom onset 2 hours ago. NIHSS 14.
Key findings: BP 204/118, HR 88 irregular. CT head: no hemorrhage. CTA: left MCA occlusion. tPA candidate (within window, no contraindications).
Management:
Teaching point: BP management in stroke differs from other hypertensive emergencies. Aggressive BP lowering in ischemic stroke expands the infarct by reducing perfusion to the penumbra. The only reason to lower BP acutely is to safely give tPA. AHA/ASA Stroke Guidelines, 2019
Patient: 42F, no prior medical history, presents with episodic severe headaches, palpitations, and diaphoresis. In the ED, BP spikes to 260/150 with HR 132 during a paroxysm.
Key findings: Between episodes: BP 145/90. 24h urine metanephrines: 4x upper normal. CT abdomen: 4.2 cm right adrenal mass. Plasma-free metanephrines markedly elevated.
Management:
Teaching point: Pheochromocytoma hypertensive crisis requires alpha-blockade FIRST. Beta-blockers before alpha-blockade removes the beta-2 vasodilatory counterbalance, leaving unopposed alpha vasoconstriction. This is one of the most testable concepts in medicine.
| Parameter | Frequency | Target / Action |
|---|---|---|
| Arterial line BP | Continuous (art line mandatory in ICU) | Reduce MAP no more than 25% in the first hour. Cuff pressures are insufficient for IV drip titration -art line is standard of care. |
| MAP during titration | q5–15 min while adjusting IV drip | First hour: ≤ 25% MAP reduction. Next 2–6h: target ~160/100. Next 24–48h: gradual normalization. Too fast → watershed stroke. |
| Neuro checks | q1–2h during active titration | GCS, pupil reactivity, focal deficits, level of consciousness. New deficit during BP lowering → stop titration, allow BP to rise, urgent imaging (stroke?). |
| Urine output | q1h (Foley) | UOP ≥ 0.5 mL/kg/hr. Declining UOP during BP reduction = renal hypoperfusion -may need to allow higher BP target. |
| Creatinine | q12–24h | Trend from baseline. Rising Cr suggests renal end-organ injury or overly aggressive BP lowering. Adjust target accordingly. |
| Troponin | On admission, repeat at 6h if elevated or ongoing chest pain | Hypertensive emergency can cause demand ischemia (type 2 MI). Elevated troponin changes management -cardiology consult. |
| Fundoscopic exam | On admission, repeat if worsening | Papilledema, flame hemorrhages, cotton-wool spots, AV nicking. Presence confirms end-organ damage and classifies as true emergency vs urgency. |
| Transition to oral agents | After 12–24h stable on IV drip | Start long-acting oral antihypertensives (amlodipine, lisinopril, etc.) with IV drip overlap. Wean drip gradually as oral agents take effect (24–48h). Do not abruptly stop IV. |